Plexxikon is Pharmaceuticals in United States that focus on colorectal cancer business. Founded in 2000. They cover business area such as developer, small molecule pharmaceutical, human disease, diabetes, melanoma, colorectal cancer, inhibitor, pain, polycystic kidney disease, arthritis, metastatic breast cancer, renal disease, a portfolio, various therapeutic area, metabolic disease, obesity indication, oncology, osteolytic metastatic disease, CNS, multiple sclerosis.
2000
( 24 years old in 2024 )
Colorectal Cancer
-
91 Bolivar Drive
Berkeley, CA 94710
United States
Private
developersmall molecule pharmaceuticalhuman diseasediabetesmelanomacolorectal cancerinhibitorpainpolycystic kidney diseasearthritismetastatic breast cancerrenal diseasea portfoliovarious therapeutic areametabolic diseaseobesity indicationoncologyosteolytic metastatic diseaseCNSmultiple sclerosis
* We use standard office opening hours in near Plexxikon's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Plexxikon is Pharmaceuticals business from United States that founded in 2000 (24 years old in 2024), Plexxikon business is focusing on Colorectal Cancer.
Plexxikon headquarter office and corporate office address is located in 91 Bolivar Drive Berkeley, CA 94710 United States.
Plexxikon was founded in United States.
In 2024, Plexxikon is currently focus on colorectal cancer sector.
Above is snippet of Google Trends for "colorectal cancer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Plexxikon, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
